The role of the adrenalectomy in the management of pheochromocytoma: the experience of a Portuguese referral center

Author:

Carvalho Ines Costa1,Machado Miguel V.B.2,Morais João P.1,Carvalho Filipa1,Barbosa Elisabete2,Barbosa José2

Affiliation:

1. University of Porto

2. Centro Hospitalar Universitário de São João

Abstract

Abstract

Purpose Pheochromocytoma is a rare neuroendocrine tumor. Despite the low incidence, these tumors are of indisputable importance. This study aimed to analyze the management of pheochromocytoma in a referral center, with an emphasis on the minimally invasive adrenalectomy, which is the preferred therapeutic approach. Methods A retrospective analysis was performed on a cohort of patients diagnosed with pheochromocytoma who underwent adrenalectomy between January 2013 and December 2022. Clinical data including demographics, timelines, symptomatology, comorbidities, biochemical markers, genetic testing, surgical details, and follow-up outcomes, were collected and analyzed. Results The cohort included 44 patients, predominantly women (52,27%), with a median age of 53,39 years (range 13–83). Most of patients exhibited paroxysmal symptoms suggesting catecholamine excess. Documented hypertension was the most frequent (86,36%), along with glucose anomalies (40,01%) and anxiety disorder (31,82%). Genetic testing was performed in 36 (81,81%) patients and 14 (38,88%) revealed a positive result, predominantly RET pathogenic variant. Laparoscopic surgery was performed in 34 (79,07%) patients, showing significantly shorter operative time (2,5 hours vs. 4,25 hours, t-test p < 0,001) and fewer complications (23,53% vs 77,78%, p = 0,008). Postoperative complications occurred in 36,36% of the patients, mostly mild (grade I, 56,25%), with no mortality. SDHB pathogenic variant correlated with both recurrent and metastatic disease (p = 0.006). One-year follow-up reported 9.09% recurrence and 6.82% metastasis. Conclusions Adrenalectomy demonstrated a high safety and effectiveness. This study exhibited a higher rate of genetic testing referral than other studies. Despite past advances, there is still a need for further studies to establish protocols and evaluate new techniques.

Publisher

Research Square Platform LLC

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3